Bayer
Pharma

Bayer scores €3B capital equity infusion in deal with Apollo

Bayer has signed a deal to secure 3B euros in equity with Apollo, surrendering a minority, non-controlling stake in its contraceptives business.
Kevin Dunleavy Jul 10, 2026 11:31am
Thumbnail from BioMarins PKU podcast

Young people with PKU take the mic in BioMarin podcast series

Jul 10, 2026 11:28am
FDA stop sign

FDA rejects Hengrui, Elevar PD-1 liver cancer combo a 3rd time

Jul 10, 2026 10:55am
Magnifying glass with pills on blue

Regulatory tracker: NICE shoots down Lumakras reimbursement

Jul 10, 2026 10:21am
Sanofi headquarters Sanofi

After FDA delay, Sanofi scores subcutaneous OBI nod for Sarclisa

Jul 10, 2026 9:18am
A blue-toned graphic showing assorted pills and capsules scattered across a close-up of a 100 bill with Benjamin Franklin

A $10B deal, China trial scrutiny and highlights from ADA 2026

Jul 10, 2026 9:18am
More News

AZ's China deals, Kailera-Hengrui—Fierce Pharma Asia

Jul 10, 2026 8:51am

Sobi tops bleeding disorder patient groups' reputation rankings

Jul 9, 2026 6:06pm

BioNTech lays commercial groundwork for PD-L1xVEGF via HER2 ADC

Jul 9, 2026 2:17pm

AstraZeneca, Ionis shares slide with ATTR-CM trial failure

Jul 9, 2026 11:36am